Dr. Arielle Elkrief, MD
Claim this profileCentre hospitalier de l'Université de Montréal (CHUM)
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
4 drugs studied
Area of expertise
1Lung Cancer
Stage IV
PD-L1 positive
2Non-Small Cell Lung Cancer
Stage IV
PD-L1 positive
Affiliated Hospitals
Clinical Trials Arielle Elkrief, MD is currently running
Camu Camu + ICI
for Non-Small Cell Lung Cancer
This trial uses a natural berry supplement to improve gut health in patients with advanced lung cancer and melanoma. These patients often do not respond well to current treatments. The supplement works by increasing beneficial gut bacteria, potentially making cancer treatments more effective. Berries have shown potential against several cancers, including lung cancer and melanoma, by influencing cellular processes and improving gut health.
Recruiting1 award Phase 116 criteria
High Fiber Diet
for Lung Cancer
This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.
Recruiting1 award N/A4 criteria
More about Arielle Elkrief, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Arielle Elkrief, MD has experience with
- Camu Camu Capsules
- Immune Checkpoint Inhibitors
- Dietary Intervention
- Fecal Microbial Transplantation
Breakdown of trials Arielle Elkrief, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Arielle Elkrief, MD specialize in?
Arielle Elkrief, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Arielle Elkrief, MD currently recruiting for clinical trials?
Yes, Arielle Elkrief, MD is currently recruiting for 2 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Arielle Elkrief, MD has studied deeply?
Yes, Arielle Elkrief, MD has studied treatments such as Camu Camu Capsules, Immune Checkpoint Inhibitors, Dietary Intervention.
What is the best way to schedule an appointment with Arielle Elkrief, MD?
Apply for one of the trials that Arielle Elkrief, MD is conducting.
What is the office address of Arielle Elkrief, MD?
The office of Arielle Elkrief, MD is located at: Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec H2X 3E4 Canada. This is the address for their practice at the Centre hospitalier de l'Université de Montréal (CHUM).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.